<code id='EBCE896557'></code><style id='EBCE896557'></style>

<acronym id='EBCE896557'></acronym>

<center id='EBCE896557'><center id='EBCE896557'><tfoot id='EBCE896557'></tfoot></center><abbr id='EBCE896557'><dir id='EBCE896557'><tfoot id='EBCE896557'></tfoot><noframes id='EBCE896557'>

<optgroup id='EBCE896557'><strike id='EBCE896557'><sup id='EBCE896557'></sup></strike><code id='EBCE896557'></code></optgroup>

<b id='EBCE896557'><label id='EBCE896557'><select id='EBCE896557'><dt id='EBCE896557'><span id='EBCE896557'></span></dt></select></label></b><u id='EBCE896557'></u>

~~<i id='EBCE896557'><strike id='EBCE896557'><tt id='EBCE896557'><pre id='EBCE896557'></pre></tt></strike></i>~~

Home» Wikipedia» comprehensive

comprehensive

comprehensive

author：comprehensive 2025-09-29 09:08:18 Page View：3

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

advertisement

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+
Next article： At least 13 dead in Texas as scorching temps continue

leisure time

How one medical school became remarkably diverse

How one medical school became remarkably diverse

ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

U.K. considers world's first use of meningitis vaccine to address gonorrhea

U.K. considers world's first use of meningitis vaccine to address gonorrhea

ColorizedscanningelectronmicrographofNeisseriagonorrhoeaebacteria,whichcausesgonorrhea.NIAIDAnexpert

The cancer drug shortage isn’t new — and neither are the solutions

The cancer drug shortage isn’t new — and neither are the solutions

PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

Anthos stroke drug appears safer than common blood thinner

AdobePHILADELPHIA—Aninvestigationaldrugaimedatpreventingstrokessignificantlyreducedtheriskofbleeding

read more